返回 Agenda
Session 5: Panel Discussion
Session Chair(s)
Rei Maeda
Consultant
Independent Consultant for Drug PV, Japan
Hiroyuki Murakami, PHD
Duputy Review Director, Office of New Drug I
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Nihonbashi Life Science Building - Hall 201
2017 年 05 月 30 日 9:20 上午 - 2017 年 05 月 30 日 5:45 下午
2-3-11 Nihonbashi-honcho, Chuo-ku, Tokyo, 103-0023 Japan
返回 Agenda
Consultant
Independent Consultant for Drug PV, Japan
Duputy Review Director, Office of New Drug I
Pharmaceuticals and Medical Devices Agency (PMDA), Japan